reports
United Rentals Inc: 1 director
A director at United Rentals Inc sold 559 shares at 674.564USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
- Jonathan Moreland
RF REGIONS FINANCIAL CORPORATION
NEOG NEOGEN CORPORATION
LGND LIGAND PHARMACEUTICALS INCORPORATED
INTC INTEL CORPORATION
HXL HEXCEL CORPORATION
FFIN FIRST FINANCIAL BANKSHARES INC
EGBN EAGLE BANCORP INC.
DLTR DOLLAR TREE INC.
CINF CINCINNATI FINANCIAL CORPORATION
CHDN CHURCHILL DOWNS INCORPORATED
SWKS SKYWORKS SOLUTIONS INC.
HTLD HEARTLAND EXPRESS INC.
ZUMZ ZUMIEZ INC.
TRT TRIO TECH INTERNATIONAL
CET CENTRAL SECURITIES CORP.
LIND LINDBLAD EXPEDITIONS HOLDINGS
WDFC WD-40 COMPANY
FEIM FREQUENCY ELECTRONICS INC.
AINC ASHFORD
CLF CLIFFS NATURAL RESOURCES INC.
PWOD PENNS WOODS BANCORP INC.
ATOM ATOMERA
LOVE LOVESAC
FVCB FVCBANKCORP
INMB INMUNE BIO
MCFT INC.
CAPR MASTERCRAFT BOAT HOLDINGS
RYES CAPRICOR THERAPEUTICS
HQL PATRIOT MINEFINDERS INC.
SOWG TEKLA LIFE SCIENCES INVESTORS
CPZ SOW GOOD INC.
AUID CALAMOS LONG/SHORT EQUITY AND DYNAMIC INCOME TRUST
JBHT IPSIDY INC.
TBBK J.B. HUNT TRANSPORT SERVICES
MPA INC.
FTHY THE BANCORP
AIKI INC.
BHVN BLACKROCK MUNIYIELD PENNSYLVANIA FD
BUKS FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
ACRV AIKIDO PHARMA INC.
ZURA BIOHAVEN LTD
ABEO BUTLER NATIONAL CORP
STCN ACRIVON THERAPEUTICS INC
KRRO ZURA BIO LTD
LSXMA ABEONA THERAPEUTICS INC.
EP STEEL CONNECT INC
INTZ KORRO BIO INC
LGVN LIBERTY SIRIUSXM GROUP
OCX EMPIRE PETROLEUM CORP
EYPT INTRUSION INC
IZEA LONGEVERON INC
CFFI ONCOCYTE CORPORATION
EYEPOINT PHARMACEUTICALS
INC.
IZEA WORLDWIDE INC
C&F FINANCIAL CORPORATION
Crown Castle Files Investor Presentation Highlighting Clear Strategic ...
Crown Castle Files Investor Presentation Highlighting Clear Strategic Plan and Refreshed, Experienced Board to Drive Shareholder Value Creation The Company’s Board, alongside newly appointed CEO Steven Moskowitz, is taking action to improve performance, unlock value within the fiber and small cell business, and create a stronger and more valuable Crown Castle Ted Miller’s demands to take de facto control of the Company, along with three of his friends and family, put shareholders’ investment in Crown Castle at risk Shareholders urged to vote the WHITE proxy card or voting instruction form...
Soleno Therapeutics Announces Pricing of Approximately $138 Million Pu...
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today the pricing of the underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $46.00 per share. The gross proceeds of the public offering are expected to be approximately $138.0 million, before deducting ...
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule ...
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CHARLESTOWN, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 38,508 restricted stock units (“RSUs”) to two newly hired employees. The RSUs vest in four equal installments on each one-year anniversary of the applicable employee’s start date until the fourth anniversary of the applicable employee’s start date. Vesting of the equity award...
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
Soleno Therapeutics Announces Proposed Public Offering of Common Stock REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. In addition, Soleno intends to grant the underwriters a 30-day option to purchase an additional number of shares of common stock equal to 15% of the aggregate number of shares o...
Moody's Ratings affirms W&T Offshore's B3 CFR with negative outlook
Moody's Ratings (Moody's) changed W&T Offshore, Inc.'s (W&T) outlook to negative, from stable previously. Concurrently, Moody's affirmed W&T's B3 Corporate Family Rating (CFR), B3-PD Probability of Default Rating (PDR), and Caa1 senior secured second lien notes rating. "The change in W&T's outlook...
Inuvo to Host First Quarter 2024 Financial Results Conference Call on ...
Inuvo to Host First Quarter 2024 Financial Results Conference Call on Tuesday, May 7th at 4:15 P.M. ET LITTLE ROCK, Ark., May 01, 2024 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), provider of the first generative artificial intelligence (AI) advertiser solution made specifically for brands and agencies, will host a conference call on Tuesday, May 7, 2024, at 4:15 P.M. Eastern Time to discuss its financial results and provide a business update for the for the first quarter ended March 31, 2024. Conference Call Details: Date: Tuesday, May 7, 2024Time: 4:15 P.M. Eastern Time Toll-...
Merit Medical Reports Results for First Quarter Ended March 31, 2024
Merit Medical Reports Results for First Quarter Ended March 31, 2024 Q1 2024 reported revenue of $323.5 million, up 8.7% compared to Q1 2023Q1 2024 constant currency revenue* up 9.3% compared to Q1 2023Q1 2024 constant currency revenue, organic* up 7.0% compared to Q1 2023Q1 2024 GAAP operating margin of 11.1%, compared to 8.9% in Q1 2023Q1 2024 non-GAAP operating margin* of 17.3%, compared to 16.1% in Q1 2023Q1 2024 GAAP EPS $0.48, up 35.5%, compared to $0.36 in Q1 2023Q1 2024 non-GAAP EPS* $0.77, up 18.7%, compared to $0.64 in Q1 2023 * Constant currency revenue; constant currency revenu...
Inuvo Announces Enhancements to its Audience Discovery Portal
Inuvo Announces Enhancements to its Audience Discovery Portal IntentKey AI can now associate any product, brand, or service to trending events LITTLE ROCK, Ark., April 30, 2024 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), provider of the first generative artificial intelligence (AI) advertiser solution made specifically for brands and agencies, today announces a significant enhancement to its Audience Discovery Portal, the latest version of a first-of-its-kind intelligence capable of instantly generating marketing audience insights. Powered by IntentKey AI, a proprietary larg...
Soleno Therapeutics Announces Peer-Reviewed Publication of Data Compar...
Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome Statistically Significant Improvements with DCCR Compared to Natural History of PWS from the PATH for PWS Study in Hyperphagia and PWS-related Behaviors REDWOOD CITY, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the publication of the comparison of results from the Company’s Phase ...
MVB Financial Corp. Announces First Quarter 2024 Results
FAIRMONT, W.Va.--(BUSINESS WIRE)-- MVB Financial Corp. (NASDAQ: MVBF) (“MVB Financial,” “MVB” or the “Company”), the holding company for MVB Bank, Inc. ("MVB Bank"), today announced financial results for the first quarter of 2024, with reported net income of $4.5 million, or $0.35 basic and $0.34 diluted earnings per share. First Quarter 2024 Highlights As Compared to Fourth Quarter 2023 Total revenue increased 6.8%, or $2.4 million. Fintech fee income grew 26.3%, or $1.0 million. Noninterest bearing deposits increased 16.2%, or $193.8 million, and represent 44% of total deposits. No...
Esperion to Participate in Upcoming May Investor Conferences
Esperion to Participate in Upcoming May Investor Conferences ANN ARBOR, Mich., April 29, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of May, which can be found on our investor relations . JMP Securities’ Life Sciences Conference in New York on May 13, 2024, at 2:30 p.m. ET. Bank of America Securities’ 2024 Health Care Conference in Las Vegas on May 15, 2024, at 3:00 p.m. PT / 6:00 p.m. ET. H.C. Wainwright’s 2nd Annual BioConnect Investor Conference in New York on May ...
Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S...
Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS) First Ever Breakthrough Designation for a Drug Being Developed for PWS Designation is Based on Data from the Phase 3 Program for DCCR Planned Submission of a New Drug Application (NDA) for DCCR Remains on Track for Mid-2024 REDWOOD CITY, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
RGLD ROYAL GOLD INC
URI UNITED RENTALS INC.
DOV DOVER CORPORATION
MTH MERITAGE HOMES CORPORATION
MRK MERCK & CO. INC.
FORM FORMFACTOR INC.
CPF CENTRAL PACIFIC FINANCIAL CORP.
CHDN CHURCHILL DOWNS INCORPORATED
AR ANTERO RESOURCES CORPORATION
UVSP UNIVEST FINANCIAL CORPORATION
VIRT VIRTU FINANCIAL INC. CLASS A
NOC NORTHROP GRUMMAN CORPORATION
CECE CECO ENVIRONMENTAL CORP.
CMG CHIPOTLE MEXICAN GRILL INC.
PI IMPINJ INC.
MRUS MERUS B V
ADES ADVANCED EMISSIONS SOLUTIONS
HCC WARRIOR MET COAL INC.
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
KDP KEURIG DR PEPPER INC.
MMMB MAMAMANCINI'S HOLDINGS INC
FXI ISHARES CHINA LARGE-CAP ETF
STRA STRATEGIC EDUCATION INC.
DELL DELL TECHNOLOGIES INC CLASS C
TNK TEEKAY TANKERS
AIMD.P AIM4 VENTURES
ALXO ALX ONCOLOGY HOLDINGS
CSU CAPITAL SENIOR LIVING
LRN STRIDE INC
VRT VERTIV HOLDINGS CO (A)
AMR ALPHA METALLURGICAL RESOURCES INC
RSVR RESERVOIR MEDIA
CADL INC.
SG CANDEL THERAPEUTICS INC
EEMA SWEETGREEN INC
CASH ONTO INNOVATION INC.
FEBO ISHARES MSCI EMERGING MARKETS ASIA INDEX
METC HORIZONS HIGH INTEREST SAVINGS ETF
PROP FENBO HOLDINGS LIMITED
AESI RAMACO RESOURCES INC.
PRAIRIE OPERATING CO.
ATLAS ENERGY SOLUTIONS INC CL A
Crown Castle Highlights Actions its Board Has Implemented to Successfu...
Crown Castle Highlights Actions its Board Has Implemented to Successfully Strengthen Foundation and Position Company for Long-Term Value Creation Urges Shareholders to Vote “FOR” ONLY Crown Castle’s 12 Qualified and Experienced Director Nominees on the WHITE Proxy Card Ted Miller’s Self-Serving Campaign Risks Derailing Important Work Underway and Is Not Aligned with Interests of Shareholders HOUSTON, April 25, 2024 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) (“Crown Castle” or the “Company”) today sent a letter to shareholders in connection with its upcoming 2024 Annual Meeting of...
Eyenovia Provides Clinical and Scientific Update on FDA-Approved Produ...
Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension Company announces results from a Phase IV study of Mydcombi designed to characterize the efficacy and duration of the lowest deliverable dose (one 8µL spray per eye) Also announces upcoming ARVO presentation on the unique technology behind clobetasol that allows for future ophthalmic suspensions to be dispensed with the Optejet® NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: EYEN), a commercial-stage ophthalmic company, today provided an upd...
Bread Financial™ Provides Performance Update for March 2024
Bread Financial™ Provides Performance Update for March 2024 COLUMBUS, Ohio, April 25, 2024 (GLOBE NEWSWIRE) -- (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending and saving solutions, provided a performance update. The following tables present the Company’s net loss rate and delinquency rate for the periods indicated. For themonth endedMarch 31, 2024 For thethree months endedMarch 31, 2024 (dollars in millions)End-of-period credit card and other loans$18,185 $18,185 Average credit card and other loans (1)$18,191 $18,546 Year-ov...
Bread Financial™ Reports First Quarter 2024 Results
Bread Financial™ Reports First Quarter 2024 Results COLUMBUS, Ohio, April 25, 2024 (GLOBE NEWSWIRE) -- (NYSE: BFH), a tech-forward financial services company that provides simple, flexible payment, lending and saving solutions, today announced its first quarter 2024 financial results. All earnings-related materials are now available at the company’s investor relations website, . Bread Financial President and Chief Executive Officer Ralph Andretta and Chief Financial Officer Perry Beberman will host a conference call at 8:30 a.m. ET today to discuss results. A link to the conference ca...
Bread Financial™ Declares Dividend on Common Stock
Bread Financial™ Declares Dividend on Common Stock COLUMBUS, Ohio, April 25, 2024 (GLOBE NEWSWIRE) -- (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending and saving solutions, today announced that its Board of Directors declared a quarterly cash dividend of $0.21 per share on the Company’s common stock, payable on June 14, 2024 to stockholders of record at the close of business on May 10, 2024. About Bread Financial™ (NYSE: BFH) is a tech-forward financial services company providing simple, personalized payment, lending and saving ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.